SCHEMBL3737375

SCHEMBL3737375

Cc1ccc(C)n1-c1cccc(C2CCN(C(=O)O)CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 11/20 0.39
DRD2 P14416 10/20 0.39
HTR1A P08908 8/20 0.39
KDM5A P29375 1/20 0.38
UBE2M P61081 2/20 0.38
DCUN1D1 Q96GG9 2/20 0.38
LMNA P02545 1/20 0.38
KCNH2 Q12809 4/20 0.36
CNR2 P34972 2/20 0.36
ACACB O00763 1/20 0.36
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
POLB P06746 1/20 0.35
MYC P01106 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275976 0.83 GPR119 (0.49)
SCHEMBL20139993 0.82 DRD2 (0.54) DRD4DRD2HTR1AKDM5AUBE2M
SCHEMBL29556164 0.77 CNR2 (0.41) DRD4DRD2HTR1AKDM5AUBE2M
SCHEMBL15140526 0.77 CNR2 (0.41) DRD4DRD2HTR1AKDM5AUBE2M
SCHEMBL20266326 0.76 UBE2M (0.41) DRD4DRD2HTR1AKDM5AUBE2M
SCHEMBL29924785 0.76 UBE2M (0.41) DRD4DRD2HTR1AKDM5AUBE2M
SCHEMBL9943901 0.76 CNR2 (0.49) DRD4DRD2HTR1AKDM5AUBE2M
SCHEMBL29668662 0.76 HTR1A (0.50) DRD4DRD2HTR1AKDM5AUBE2M
SCHEMBL274852 0.76 PIM1 (0.48)
SCHEMBL21597925 0.76 HTR1A (0.53) DRD4DRD2HTR1AUBE2MDCUN1D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825119-B2 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate GALAPAGOS SAS (FR) 2010-11-02 US disclosed